论文部分内容阅读
目的:探讨舒普深对急性肾盂肾炎临床治疗的效果。方法:选取2013年1月至2016年1月收治的急性肾盂肾炎患者160例,随机分为对照组与观察组,各80例,对照组患者给予左氧氟沙星进行治疗,观察组患者给予舒普深。比较两组患者的临床疗效及不良反应。结果:观察组患者中,痊愈31例,显效45例,有效率为95.0%,对照组中,痊愈20例,显效39例,有效率为72.9%,两组患者临床有效率比较差异具有统计学意义(P<0.05);两组不良反应比较差异无统计学意义(P>0.05)。结论:舒普深治疗急性肾盂肾炎具有较好的临床疗效,且不良反应的发生率低。
Objective: To investigate the effect of Shu Pu-Shen on the clinical treatment of acute pyelonephritis. Methods: One hundred and sixty patients with acute pyelonephritis admitted from January 2013 to January 2016 were randomly divided into control group and observation group, 80 cases in each group. Patients in the control group were treated with levofloxacin, and patients in observation group were treated with shuxunshen. The clinical efficacy and adverse reactions of the two groups were compared. Results: In the observation group, 31 cases were cured, 45 cases were markedly effective, the effective rate was 95.0%. In the control group, 20 cases were cured, 39 cases markedly effective, and the effective rate was 72.9%. There was statistically significant difference between the two groups in clinical efficiency (P <0.05). There was no significant difference in adverse reactions between the two groups (P> 0.05). Conclusion: Shu Pushen treatment of acute pyelonephritis has a good clinical efficacy, and the incidence of adverse reactions is low.